CD8A and neoplasm: Together these mechanisms explain the enhanced number of Th1 cytokine-producing CD8+ T cells in the tumor and spleen, as well as the robust increase of Ag-specific tumor-infiltrating effector CD8+ T cell responses with cytolytic potential (Figures 1, 3 & 6).